Respiratory Viruses: 2023-2024 Vaccine Update: Influenza, COVID-19, RSV, and Pneumonia-Content PDF Handout

Content PDF Handout

Pdf Summary

The Wild Iris Medical Education course, titled "Respiratory Viruses: 2023–2024 Vaccine Update," provides essential updates on vaccines for healthcare professionals. The course aims to address educational gaps regarding the latest vaccine recommendations for respiratory viruses including influenza, COVID-19, pneumococcal, and respiratory syncytial virus (RSV).<br /><br />Updates include the following:<br /><br />1. **Influenza Vaccine:** The CDC recommends annual influenza vaccinations for everyone aged 6 months and older, irrespective of egg allergy. The 2023–2024 flu vaccines, reviewed by the FDA, include updated strains to better match circulating viruses. It's noted that coadministration with the COVID-19 vaccine is safe.<br /><br />2. **COVID-19 Vaccine:** With SARS-CoV-2 continuing to mutate, updated vaccines targeting the Omicron/XBB.1.5 subvariant have been developed. The CDC advises the public over six months to receive a monovalent vaccine dose. Vaccines will transition to the commercial market, and updated recommendations may follow annually.<br /><br />3. **Pneumococcal Vaccine:** There are two types, polysaccharide (PPSV23) and conjugate vaccines (PCV13, PCV15, and PCV20). Children, adults with specific health conditions, and those over 65 are recommended to receive these vaccines to protect against common forms of bacterial pneumonia.<br /><br />4. **RSV Vaccine:** Newly approved vaccines include Arexvy for adults aged 60 and older, Nirsevimab (Beyfortus) for infants and young children, and Abrysvo for pregnant individuals. RSV vaccines significantly reduce risks of developing severe lower respiratory tract disease.<br /><br />The course underscores the unpredictability of respiratory virus seasons, emphasizing the importance of updated vaccinations to mitigate risks of severe illness. It stresses that healthcare professionals must stay informed about these updates to deliver optimal patient care, and it provides resources for obtaining further information. The course also ensures practitioners are aware of coadministration protocols, particularly concerning the flu and COVID-19 vaccines.

Keywords

Respiratory Viruses

Vaccine Update

Influenza Vaccine

COVID-19 Vaccine

Pneumococcal Vaccine

RSV Vaccine

Healthcare Professionals

Coadministration

CDC Recommendations

FDA Approved